Gainers
Ambrx Biopharma Inc. (NYSE: AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate.
Data from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment
Tesla (TSLA)
Nvidia (NVDA)
Lululemon Athletica (LULU)
Carvana (CVNA)
Apple (AAPL)
Amazon (AMZN)
Netflix (NFLX)
DocuSign
A whale with a lot of money to spend has taken a noticeably bullish stance on DocuSign.
Looking at options history for DocuSign (NASDAQ:DOCU) we detected 14 strange trades.
Trading in the index futures suggests that U.S. stocks could get off to a slightly positive start on Friday. Notwithstanding the early signals, two key economic data will likely direct trading direction in the final session of the week.
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.